Invesco Ltd. Increases Stock Position in Crescent Capital BDC, Inc. (NASDAQ:CCAP)

Invesco Ltd. grew its holdings in Crescent Capital BDC, Inc. (NASDAQ:CCAP) by 63.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 18,286 shares of the company’s stock after buying an additional 7,067 shares during the quarter. Invesco Ltd.’s holdings in Crescent Capital BDC were worth $351,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of CCAP. Franklin Resources Inc. lifted its holdings in Crescent Capital BDC by 35.2% in the third quarter. Franklin Resources Inc. now owns 256,279 shares of the company’s stock valued at $4,726,000 after acquiring an additional 66,713 shares during the period. Redhawk Wealth Advisors Inc. acquired a new stake in shares of Crescent Capital BDC in the fourth quarter valued at about $659,000. Hennion & Walsh Asset Management Inc. boosted its holdings in Crescent Capital BDC by 11.9% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 105,343 shares of the company’s stock worth $2,025,000 after buying an additional 11,161 shares in the last quarter. Van ECK Associates Corp boosted its holdings in Crescent Capital BDC by 2.3% during the fourth quarter. Van ECK Associates Corp now owns 45,562 shares of the company’s stock worth $876,000 after buying an additional 1,006 shares in the last quarter. Finally, Montag A & Associates Inc. acquired a new position in Crescent Capital BDC during the fourth quarter worth about $35,000. 49.46% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CCAP. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $18.00 to $16.00 and set an “equal weight” rating for the company in a research report on Monday, April 28th. Keefe, Bruyette & Woods reduced their price objective on Crescent Capital BDC from $20.00 to $18.50 and set an “outperform” rating for the company in a report on Tuesday, April 8th. One equities research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $18.50.

Crescent Capital BDC Stock Up 2.0 %

CCAP stock opened at $16.01 on Friday. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.32 and a quick ratio of 1.26. The company’s 50 day simple moving average is $16.51 and its 200-day simple moving average is $18.24. Crescent Capital BDC, Inc. has a 12 month low of $13.54 and a 12 month high of $20.19. The firm has a market capitalization of $593.36 million, a PE ratio of 8.05 and a beta of 0.56.

Crescent Capital BDC (NASDAQ:CCAP) last announced its earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.01). Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. The company had revenue of $46.40 million for the quarter, compared to analyst estimates of $47.27 million. Equities analysts expect that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current fiscal year.

Crescent Capital BDC Announces Dividend

The company also recently announced a dividend, which will be paid on Friday, June 13th. Investors of record on Friday, May 30th will be paid a $0.05 dividend. The ex-dividend date of this dividend is Friday, May 30th. Crescent Capital BDC’s payout ratio is 84.42%.

Crescent Capital BDC Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.